Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Jonathan R. Thompson MD

Jonathan R. Thompson MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center
Member of the Genomic Sciences and Precision Medicine Center (GSPMC)


I am willing to collaborate on research projects.


Research Experience

  • Clinical Trials as Topic
  • Clinical Expertise

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Small Cell
  • Lung Neoplasms
  • Mesothelioma
  • Thymoma
  • Thymus Neoplasms
  • Publications (18)

  • A phase II study of bemcentinib (BGB324), a first-in-class highly selective AXL inhibitor, with pembrolizumab in pts with advanced NSCLC: OS for stage I and preliminary stage II efficacy (Enriqueta Felip, Paal Brunsvig, Nuria Vinolas, Santiago Ponce Aix, Enric Carcereny Costa, Manuel Dómine Gomez, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James F. Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J Holt, Katherine Lorens, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Emmett V. Schmidt, Michael Jon Chisamore, Matthew Krebs) J Clin Oncol J Clin Oncol 37, 2019 (suppl:abstr 9098) 06/02/2019    
  • Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. (Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C) J Immunother Cancer 2019 Feb 01;7(1):27 PMID: 30709424 PMCID: PMC6359802 SCOPUS ID: 2-s2.0-85060929943 02/03/2019       3 Citations
  • Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. (Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, Dragnev K, Tafe LJ, Zhu J, Labriola M, Marin D, McCall SJ, Clarke J, George DJ, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, de la Cruz-Merino L, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Kasuganti D, Shah N, Day R, Galluzzi L, Gardner M, Morrison C) J Immunother Cancer 2019 Jan 24;7(1):18 PMID: 30678715 PMCID: PMC6346512 SCOPUS ID: 2-s2.0-85060525068 01/27/2019       3 Citations
  • Use of Immune Checkpoint Inhibitors (ICIs) in Patients with Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS) (Jonathan R Thompson, Carlos Arce-Lara, Smitha Menon) World Conference on Lung Cancer 2018 09/25/2018    
  • Sarcopenia is Associated with Metastatic Burden and is a Negative Prognostic Factor in Metastatic Non-Small Cell Lung Cancer (Chad Glisch, Aniko Szabo, Jonathan R Thompson, Smitha Menon, Jay Patel) World Conference on Lung Cancer 2018 09/25/2018    
  • Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. (Du M, Thompson J, Fisher H, Zhang P, Huang CC, Wang L) Lung Cancer 2018 06;120:113-121 PMID: 29748005 SCOPUS ID: 2-s2.0-85045459821 05/12/2018       3 Citations
  • Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. (Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE) BMC Cancer 2018 04 02;18(1):359 PMID: 29609532 PMCID: PMC5879565 SCOPUS ID: 2-s2.0-85044841612 04/04/2018       3 Citations
  • Liquid Biopsies and Cancer Immunotherapy. (Thompson JR, Menon SP) Cancer J 2018 Mar/Apr;24(2):78-83 PMID: 29601334 SCOPUS ID: 2-s2.0-85044928489 03/31/2018       4 Citations
  • Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors (Jonathan R Thompson, Carlos Arce-Lara, Aniko Szabo, Smitha Menon) World Conference on Lung Cancer Abstract 693 10/16/2017    
  • Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 PMID: 28757436 SCOPUS ID: 2-s2.0-85028446880 08/02/2017       1 Citation
  • Applications of Extracellular RNAs in Oncology. (Thompson JR, Zhu J, Kilari D, Wang L) Mol Diagn Ther 2017 02;21(1):1-11 PMID: 27688207 SCOPUS ID: 2-s2.0-84989170631 10/01/2016       1 Citation
  • Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer (Jonathan R. Thompson, Smitha P. Menon, Grace K. Dy) ADMET & DMPK ADMET & DMPK 4(3)(2016) 186-211 09/30/2016    
  • Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. (Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS) Cancer 2014 Jul 15;120(14):2122-9 PMID: 24711253 SCOPUS ID: 2-s2.0-84903791210 04/09/2014       27 Citations
  • Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 SCOPUS ID: 2-s2.0-84882809747 06/29/2013       13 Citations
  • Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. (Ho WS, Patel S, Thompson JR, Roberts CJ, Stuhr KL, Hillard CJ) Br J Pharmacol 2010 Jun;160(3):736-46 PMID: 20590576 PMCID: PMC2931572 SCOPUS ID: 2-s2.0-77952633980 07/02/2010       7 Citations
  • Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. (Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD) Br J Pharmacol 2007 Nov;152(5):691-8 PMID: 17891162 PMCID: PMC2190024 SCOPUS ID: 2-s2.0-35649005473 09/25/2007       23 Citations
  • Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord. (Wu HE, Thompson J, Sun HS, Terashvili M, Tseng LF) J Pharmacol Exp Ther 2005 Sep;314(3):1101-8 PMID: 15901793 SCOPUS ID: 2-s2.0-23944521611 05/20/2005       24 Citations
  • Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. (Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF) J Pharmacol Exp Ther 2004 Jul;310(1):240-6 PMID: 14999057 SCOPUS ID: 2-s2.0-3042690201 03/05/2004       24 Citations
  • Last update: 07/25/2019
    jenkins-FCD Prod-388 89e904233d719332173309c68ab82b0b2a78a3a7